Intellia Therapeutics, Inc. Annual Operating Margin in % from 2016 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Intellia Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2024.
  • Intellia Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -923 %, a 35% increase year-over-year.
  • Intellia Therapeutics, Inc. annual Operating Margin for 2024 was -923 %, a 35% increase from 2023.
  • Intellia Therapeutics, Inc. annual Operating Margin for 2023 was -1.42K %, a 61.6% decline from 2022.
  • Intellia Therapeutics, Inc. annual Operating Margin for 2022 was -879 %, a 8.47% decline from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -923 +497 +35% Jan 1, 2024 Dec 31, 2024
2023 -1.42K -541 -61.6% Jan 1, 2023 Dec 31, 2023
2022 -879 -68.7 -8.47% Jan 1, 2022 Dec 31, 2022
2021 -810 -575 -244% Jan 1, 2021 Dec 31, 2021
2020 -236 +11.3 +4.56% Jan 1, 2020 Dec 31, 2020
2019 -247 +51.8 +17.3% Jan 1, 2019 Dec 31, 2019
2018 -299 -32.3 -12.1% Jan 1, 2018 Dec 31, 2018
2017 -266 -71.2 -36.5% Jan 1, 2017 Dec 31, 2017
2016 -195 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.